Table 6. Pre-treatments.
| CLL; n (% of all CLL patients) | FL; n (% of all FL patients) | |
|---|---|---|
| No pre-treatment | 0 | 3 (42,9) |
| 1 pre-treatment | 5 (62,5) | 1 (14,3) |
| 2 pre-treatments | 1 (12,5) | 2 (28,6) |
| 3 pre-treatments | 2 (25) | 0 |
| 4 pre-treatments | 0 | 1 (14,3) |
| R-Bendamustine | 7 (87,5) | 2 (28,6) |
| R-CHOP | 0 | 2 (28,6) |
| CHOP | 0 | 2 (28,6) |
| Rituximab (in combination with either CHOP, bendamustine or fludarabine/cyclophosphamide) | 8 (100) | 4 (57,1) |
| Stem cell transplantation | 0 | 0 |
Abbreviations: CHOP: Cyclophosphamide, doxorubicin (Hydroxydaunorubicin), vincristine (Oncovin®) and Prednisone-containing chemotherapy regimen.